Barclays’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88K | Buy |
37,986
+18,144
| +91% | +$42K | ﹤0.01% | 3863 |
|
|
2025
Q1 | $154K | Sell |
19,842
-12,177
| -38% | -$94.5K | ﹤0.01% | 3469 |
|
|
2024
Q4 | $150K | Buy |
32,019
+2,975
| +10% | +$13.9K | ﹤0.01% | 3637 |
|
|
2024
Q3 | $157K | Buy |
29,044
+24,906
| +602% | +$135K | ﹤0.01% | 3595 |
|
|
2024
Q2 | $37K | Buy |
+4,138
| New | +$37K | ﹤0.01% | 3777 |
|
|
2021
Q2 | – | Sell |
-1,667
| Closed | -$20K | – | 4143 |
|
|
2021
Q1 | $20K | Sell |
1,667
-1,146
| -41% | -$13.7K | ﹤0.01% | 3661 |
|
|
2020
Q4 | $48K | Hold |
2,813
| – | – | ﹤0.01% | 3190 |
|
|
2020
Q3 | $29K | Buy |
2,813
+2,812
| +281,200% | +$29K | ﹤0.01% | 3434 |
|
|
2020
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 3863 |
|